Community data
Updated 23 hours ago
Indications
Basiliximab is an immunosuppressant used together with other medicines to prevent immediate rejection in people who are receiving a kidney transplant. There are also reports of some cases of lichen planus being treated successfully with basiliximab, as an alternative to ciclosporin. No short-term side effects have been reported.
⚠️ Always consult a registered physician before taking any medicine.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Adults: In adults, Basiliximab is given as two doses of 20 mg each. Give the first 20 mg dose within 2 hours before the transplantation surgery. The second 20 mg dose is given 4 days after transplantation. Withhold the second dose if complications occur, such as severe hypersensitivity reactions to Basiliximab or graft loss.
Pediatric
In children weighing less than 35 kg, the regimen is two doses of 10 mg each. In children weighing 35 kg or more, it is two doses of 20 mg each. The first dose should be given within 2 hours before the transplantation surgery, and the second dose 4 days after transplantation. As in adults, the second dose should be withheld if complications such as severe hypersensitivity reactions to Basiliximab or graft loss occur.